Ceritinib‐associated hyperglycemia in the Japanese Adverse Drug Event Report Database

Genetic rearrangements of anaplastic lymphoma kinase contribute to the pathogenesis of non‐small‐cell lung cancer; the anaplastic lymphoma kinase inhibitor, ceritinib, is widely used, as it is effective even in patients with non‐small‐cell lung cancer resistant to other anaplastic lymphoma kinase in...

Descripción completa

Detalles Bibliográficos
Autores principales: Fujita, Haruka, Murakami, Takaaki, Tomoike, Fumiaki, Yabe, Daisuke, Inagaki, Nobuya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7232270/
https://www.ncbi.nlm.nih.gov/pubmed/31663274
http://dx.doi.org/10.1111/jdi.13168

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7232270/
https://www.ncbi.nlm.nih.gov/pubmed/31663274
http://dx.doi.org/10.1111/jdi.13168

Ejemplares similares